Illumina Partnerships

Partnership Discussions

Collaborating to Advance Genomics

As a global leader in genomics, we continually strive to offer solutions that are not only innovative, but also accessible and always reliable. Illumina partnerships help advance genomics in numerous ways, from expanding access to next-generation sequencing (NGS) to pioneering new applications and technologies, providing funding for innovative startups, and more. 

Featured Pharmaceutical & Biotech Partnerships

Some of our existing partnerships include:


Illumina and Roche partner to broaden the adoption of distributable next-generation sequencing-based testing in oncology.

Read Press Release
Bristol-Myers Squibb, Merck, Kura, & Myriad

Illumina forms multiple partnerships to develop precision oncology solutions.

Read Press Release
Loxo Oncology

Illumina and Loxo Oncology partner to develop next-generation sequencing-based pan-cancer companion diagnostics.

Read Press Release

Additional Partnerships

Discover more Illumina partnerships and collaborations designed to advance access to groundbreaking genomics solutions.

IIllumina & GenoScreen Partner on Multidrug-Resistant Tuberculosis Testing

The partnership will expand capabilities for countries most impacted by tuberculosis to more effectively detect and combat multidrug-resistant TB.

Illumina & QIAGEN Partner on Sequencing-Based Diagnostic Tests

The partnership focuses on commercializing oncology In Vitro Diagnostc (IVD) kits to support patient management and may expand to other clinical fields in the future.

Illumina & Microba Life Sciences Partner to Accelerate Microbiome Research

The partnership brings together revolutionary Illumina NGS tools and a high-quality proprietary gut microbiome analysis platform from Microba to rapidly process large volumes of metagenomic data.

Amazon Web Services (AWS) Partnership with Illumina

The partnership supports genomic analysis customers with innovative and secure, cloud-based data processing, management, and storage.

Technology Development and Integrations

We strive to offer the best possible technologies and solutions to our customers. By integrating our technology with other best-in-class solutions, we aim to improve workflows, support groundbreaking research, and continue advancing genomics.

Learn More
Illumina Accelerator

Startup Funding for Genomics Companies

With mentorship, financial support, and access to sequencers and reagents, the Illumina Accelerator is helping genomics startups launch so we can unlock the power of the genome—together.

Illumina for Startups

Genomics News

Bridging the diagnosis gap for Canada’s Indigenous children
Bridging the diagnosis gap for Canada’s Indigenous children

The Silent Genomes Project is building a first-of-its-kind variant library for First Nations, Inuit, and Métis populations

Read Article
Using analytics to improve cancer diagnosis and therapy selection
Using analytics to improve cancer diagnosis and therapy selection

Developing and automating workflows for analyzing, processing, and sharing genomic data among researchers and clinicians.

Read Interview
A liquid biopsy study offers new hope for lung cancer patients
A liquid biopsy study offers new hope for lung cancer patients

The Welsh government launches a program aimed at accelerating diagnosis and improving clinical outcomes

Read Article